BLRX

BioLineRX
BLRX

Overview Fund Trends Analyst Outlook Journalist POV

12 hedge funds and large institutions have $8.01M invested in BioLineRX in 2013 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$110K
2
+$85K
3
+$28K
4
TRCT
Tower Research Capital (TRC)
New York
+$23.1K
5
VKH
Virtu KCG Holdings
New York
+$6.73K

Top Sellers

1
-$561K
2
-$170K
3
-$147K
4
Citigroup
Citigroup
New York
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$3.19M
2
$2.07M
3
$2.05M
4
$405K
5
$85K
6
$50K
7
$37K
8
$34K
9
$29K
10
$28K
11
$28K
12
$3K
13
–